Depression Care360

A recent cohort study found that adverse childhood experiences (ACEs) are strongly associated with treatment-resistant depression (TRD), even after accounting for familial and genetic confounding.

Selective serotonin reuptake inhibitors (SSRIs) are associated with a significantly increased risk of sexual dysfunction in adults treated for depression, according to a systematic review and...

Racemic ketamine was noninferior to intranasal esketamine for reducing depressive symptoms in adults with treatment-resistant depression (TRD) over 4 weeks.

Anti-inflammatory treatments significantly reduced anhedonia and depressive symptom severity in patients with depression and elevated inflammation.

A new systematic review and network meta-analysis has found that slow antidepressant tapering combined with psychological support is as effective as continuation therapy in preventing relapse in adults with...

A retrospective analysis of wellness evaluations from pharmacy residents across Kaleida Health assessed trends in stress, well-being, burnout, grit, and imposter phenomenon to help preceptors and program...

A longitudinal analysis found that experiences of discrimination were associated with a higher risk of major depressive episodes (MDEs) among higher education students.

Ketogenic diets (KDs) were associated with modest improvements in depressive symptoms in a recent systematic review and meta-analysis.

Serial ketamine infusions failed to outperform a psychoactive placebo as an adjunctive therapy to usual inpatient care for depression.

Ammoxetine significantly reduced depressive symptoms and was well-tolerated in adult patients with MDD.